PCMF
DMAC icon

Private Capital Management (Florida)’s DiaMedica Therapeutics DMAC Stock Holding History

Private Capital Management (Florida)’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Hold
50,000
– – 0.03% 168
2026
Q1 		$339K Hold
50,000
– – 0.03% 163
2025
Q4 		$398K Hold
50,000
– – 0.04% 140
2025
Q3 		$344K Buy
+50,000
New +$271K 0.03% 131

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Private Capital Management (Florida)'s DMAC Position: Q2 2026 in Review

Private Capital Management (Florida) held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 50,000 shares worth $352K. The position accounts for 0.03% of the portfolio, ranked #168.

Private Capital Management (Florida) first reported a position in DMAC in Q3 2025 and has held it in 4 quarters since. The position peaked at $398K in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Private Capital Management (Florida) held 50,000 shares of DiaMedica Therapeutics worth $352K as of Q2 2026.
  • Private Capital Management (Florida) left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up 0.03% of Private Capital Management (Florida)'s portfolio in Q2 2026, its #168 holding.
  • Private Capital Management (Florida) first reported a position in DiaMedica Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Private Capital Management (Florida)'s DiaMedica Therapeutics position peaked at $398K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q2 2026, filed 14 Aug 2026.